A carregar...
Rationale for STING-targeted cancer immunotherapy
The efficacy of checkpoint inhibitor therapy illustrates that cancer immunotherapy, which aims to foster the host immune response against cancer to achieve durable anticancer responses, can be successfully implemented in a routine clinical practice. However, a substantial proportion of patients does...
Na minha lista:
| Publicado no: | Eur J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362072/ https://ncbi.nlm.nih.gov/pubmed/28219022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.12.028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|